E. Montenegro et al. / Tetrahedron: Asymmetry 10 (1999) 457–471
465
3.4.1. (1S,2S,6R,7R)-4-Butyl-5-[(S)-4-tolylsulfinyl]tricyclo[5.2.1.02,6 ]deca-4,8-dien-3-one (5bf-major)
[α]D23=−11.7 (c 1.4 CHCl3). IR (film) ν=2960, 2880, 1710, 1600, 1085, 1050, 810, 620 cm−1. H
1
NMR (200 MHz, CDCl3) δ=7.56, 7.35 (AB, J=8.3 Hz, 4H), 6.13 (s, 2H), 3.05 (d, J=7.7 Hz, 1H), 2.91 (s,
1H), 2.6–2.3 (m, 2H), 2.4 (s, 3H), 1.5–1.2 (m, 8H), 0.93 (t, J=6.9 Hz, 3H). 13C NMR (75.4 MHz, CDCl3)
δ=206.3 (C), 170.6 (C), 151.3 (C), 141.7 (C), 138.6 (C), 137.8 (CH), 136.9 (CH), 130.02 (CH), 124.5
(CH), 53.4 (CH), 45.3 (CH), 43.8 (CH), 42.5 (CH), 41.1 (CH2), 30.5 (CH2), 23.6 (CH2), 22.7 (CH2),
21.2 (CH3), 13.6 (CH3). MS (DIP-CI-NH3) m/e=358 (M++18, 100%), 340 (M+, 1%), 252 (M+−88, 3%),
236 (M+−104, 5%). Conditions for HPLC analysis: Nucleosil C18 (25 cm) column, 60% CH3CN, 0.7
mL/min, λ=254 nm, tR (min)=22.43.
3.4.2. (1R,2R,6S,7S)-4-Butyl-5-[(S)-4-tolylsulfinyl]tricyclo[5.2.1.02,6 ]deca-4,8-dien-3-one (5bf-minor)
[α]D23=−12.4 (c 1.0 CHCl3). IR (film) ν=2960, 2880, 1710, 1600, 1500, 1085, 1050, 810 cm−1. H
1
NMR (200 MHz, CDCl3) δ=7.55, 7.35 (AB, J=8.1 Hz, 4H), 6.3–6.1 (m, 2H), 3.42 (s, 1H), 2.92 (s, 1H),
2.43 (s, 3H), 2.68, 2.25 (AB, J=7.7 Hz, 2H), 1.45–1.26 (m, 8H), 0.94 (t, J=6.5 Hz, 3H). 13C NMR (75.4
MHz, CDCl3) δ=207.3 (C), 171 (C), 150.1 (C), 140.2 (C), 138.8 (CH), 136.6 (CH), 130.1 (CH), 124.3
(CH), 53.4 (CH), 45.3 (CH), 43.8 (CH), 42.5 (CH), 41.1 CH2). 30.5 (CH2), 23.6 (CH2), 22.7 (CH2), 21.2
(CH3), 13.6 (CH3). MS (DIP-CI-NH3) m/e=358 (M++18, 33%), 341 (M++1, 2%), 236 (M+−104, 100%).
Conditions for HPLC analysis: Nucleosil C18 (25 cm) column, 60% CH3CN, 0.7 mL/min, λ=254 nm, tR
(min)=23.30.
3.4.3. 5-(1-Hydroxybutyl)tricyclo[5.2.1.02,6]deca-4,8-dien-3-one (6bf)
1
IR (film) ν=3450 (b), 2970, 2880, 1775, 1700, 1610, 730, 715 cm−1. H NMR (200 MHz, CDCl3)
δ=6.24 (s, 1H), 4.55 (m, 1H), 2.94 (s, 1H), 2.78 (m, 1H), 2.38 (d, J=5 Hz, 1H), 2.09 (a, 1H), 1.75–1.3 (m,
9H), 0.98 (t, J=7 Hz, 3H). 13C NMR (50 MHz, CDCl3) δ=209.1 (C), 184.9 (C), 138.2 (CH, minor), 137.8
(CH), 137.6 (CH), 137.3 (CH, minor), 132.9 (CH, minor), 132.1 (CH), 70.6 (CH), 70.5 (CH, minor), 53.6
(CH), 49.6 (CH), 43.4 (CH, minor), 43.2 (CH), 42.9 (CH, minor), 42.4 (CH), 41.4 (CH2), 41.1 (CH2,
minor), 37.9 (CH2), 18.6 (CH2, minor), 18.4 (CH2), 13.8 (CH3). MS (DIP-EI) m/e=218 (M+, 5%), 175
(M+−43, 22%), 146 (M+−72, 43%), 117 (M+−101, 57%), 91 (M+−127, 100%).
3.5. Pauson–Khand reactions of 1-hexynyl p-tolyl (+)-(S)-sulfoxide (1b) with norbornene
The general procedure A (65°C for 27 h) using as reagents 1b (100 mg, 0.45 mmol), toluene (15 mL),
Co2(CO)8 (163 mg, 0.48 mmol) and norbornene (423 mg, 4.5 mmol) afforded 52 mg of 5be as a mixture
of two diastereomers separable by chromatography (34%, 1.8:1 dr).
The general procedure B using as reagents 1b (200 mg, 0.91 mmol), CH2Cl2, of Co2(CO)8 (342 mg,
0.1 mmol), norbornene (428 mg, 4.5 mmol) and NMO (640 mg, 0.54 mmol) afforded 14 mg (4%) of
5be.
3.5.1. (1R,2S,6R,7S)-4-Butyl-5-[(S)-4-tolylsulfinyl]tricyclo[5.2.1.02,6 ]dec-4-en-3-one (5be-major)
[α]D23=+29.4 (c 1.1 acetone). IR (film) ν=2950, 2870, 1705, 1085, 1050, 810 cm−1. H NMR (500
1
MHz, CDCl3) δ=7.54, 7.34 (AB, J=8.5 Hz, 4H), 2.86, 2.23 (AB, J=6 Hz, 2H), 2.61–2.46 (m, 2H), 2.43
(s, 3H), 2.4 (s, 1H), 1.93 (s, 1H), 1.56–1.19 (m, 8H), 0.93 (t, J=7 Hz, 3H), 0.81–0.79 (m, 2H). 13C NMR
(125.7 MHz, CDCl3) δ=207.9 (C), 170.7 (C), 150.4 (C), 141.9 (C), 138.9 (C), 124.7 (CH), 130.1 (CH),
54.5 (CH), 46.2 (CH), 39.4 (CH), 37.8 (CH), 31.2 (CH2), 30.6 (CH2), 28.5 (CH2), 28.2 (CH2), 23.4
(CH2), 22.8 (CH2), 21.3 (CH3), 13.7 (CH3). MS (DIP-EI) m/e=342 (M+, 2%), 325 (M+−17, 100%), 283
(M+−59, 21%), 203 (M+−139, 2%).